EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway

Mengying Jin, Xiao Chen, Lanzhuoying Zheng, Yuanyuan Peng, Mingying Lin, Ke Liang, Xinran Liu, Zihan Xu, Yiming Yang, Baozhu Wei, Jing Wan

Archives of Biochemistry and Biophysics · 2025

DOI: 10.1016/j.abb.2025.110316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2025. Verfasst von Mengying Jin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electron…. Hauptthemen laut MEDLINE: Ferroptosis, Atherosclerosis, Nanoparticles, Macrophages. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Scholarship Council, Zhongnan Hospital of Wuhan University, Natural Science Foundation of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Astaxanthin (ASX), a fat-soluble carotenoid mainly sourced from Haematococcus pluvialis, shows promise for clinical applications in chronic inflammatory diseases. This study investigates whether ASX can mitigate atherosclerosis (AS) by modulating macrophage ferroptosis and provides astaxanthin-loaded polylactic acid-glycolic acid nanoparticles (ASX-PLGA NPs) as comparison. METHOD: ApoE-/- mice were fed a high-fat diet with ASX or statin intervention. Plaque area, lipid aggregation, collagen content, and ferroptosis-related indicators were assessed. Moreover, ASX-PLGA NPs were synthesized and characterized and were used to pretreat macrophages induced with oxidized low-density lipoprotein (ox-LDL). Indicators linked to ferroptosis and oxidative stress were detected. Finally, the expression of nuclear factor erythroid -related factor 2 (NRF2) was evaluated. RESULTS: ASX intervention significantly delayed the progression of AS plaques, characterized by reductions in plaque area and increased collagen fibers. The observed improvements in AS were consistent with statins. ASX-PLGA NPs demonstrate good safety and stability and have better therapeutic effects than ASX alone. Indicators linked to ferroptosis and oxidative stress were significantly improved in groups containing ASX in vivo and vitro. Additionally, ASX facilitated the nuclear translocation of NRF2, which could be attenuated with ML385, a specific inhibitor of NRF2. CONCLUSION: ASX-PLGA NPs have better therapeutic effects than ASX alone. The regulation of NRF2/SLC7A11/GPX4 represents a novel mechanism by which ASX can counteract ferroptosis and impede AS progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAtherosclerosisNanoparticlesMacrophagesPolylactic Acid-Polyglycolic Acid CopolymerAnimalsNF-E2-Related Factor 2MiceXanthophyllsPhospholipid Hydroperoxide Glutathione PeroxidaseMaleSignal TransductionMice, Inbred C57BL

Stichwörter der Autor:innen

AstaxanthinAtherosclerosisFerroptosisNRF2Oxidative stressPLGA NPs

Substanzen

NF-E2-Related Factor 2astaxanthineNfe2l2 protein, mouseXanthophyllsPhospholipid Hydroperoxide Glutathione PeroxidasePolylactic Acid-Polyglycolic Acid Copolymerglutathione peroxidase 4, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 2017302180262@whu.edu.cn.
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 2019305232008@whu.edu.cn.
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 865546617@qq.com.
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: pengyy@whu.edu.cn.
  • Department of Cardiology, Hainan General Hospital and Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, China. Electronic address: linliavia@outlook.com.
  • Department of Cardiology, Zhongnan Hospital of Wuhan University, No 169 Donghu Road, Wuchang District, Wuhan, 430071, Hubei Province, China. Electronic address: 303516390@qq.com.

Förderung

  • China Scholarship Council
  • Zhongnan Hospital of Wuhan University
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Jin, M., Chen, X., Zheng, L., Peng, Y., Lin, M., Liang, K., Liu, X., Xu, Z., Yang, Y., Wei, B., & Wan, J. (2025). Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2025.110316

Vancouver

Jin M, Chen X, Zheng L, Peng Y, Lin M, Liang K, et al. Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway. Archives of Biochemistry and Biophysics. 2025. doi:10.1016/j.abb.2025.110316

BibTeX
@article{Jin2025,
  author = {Jin, Mengying and Chen, Xiao and Zheng, Lanzhuoying and Peng, Yuanyuan and Lin, Mingying and Liang, Ke and Liu, Xinran and Xu, Zihan and Yang, Yiming and Wei, Baozhu and Wan, Jing},
  title = {Astaxanthin-loaded polylactic acid-glycolic acid nanoparticles alleviates atherosclerosis by suppressing macrophage ferroptosis via the NRF2/SLC7A11/GPX4 pathway},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2025},
  doi = {10.1016/j.abb.2025.110316}
}
Kostenlos starten →